End Cash: The amount of cash held by the company for the given period.
Boston Scientific Corporation (BSX) had End Cash of $2.15B for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$20.07B |
|
$2.90B |
|
$6.22B |
|
$13.85B |
|
$16.46B |
|
$3.61B |
|
$-228.00M |
|
$3.38B |
|
$3.38B |
|
$2.89B |
|
$2.89B |
|
$2.89B |
|
$2.89B |
|
$3.61B |
|
$5.03B |
|
1.48B |
|
1.49B |
|
$1.96 |
|
$1.94 |
|
| Balance Sheet Financials | |
$8.79B |
|
$4.04B |
|
$34.88B |
|
$43.67B |
|
$5.44B |
|
$11.14B |
|
$13.76B |
|
$19.20B |
|
$24.47B |
|
$-829.00M |
|
$24.47B |
|
1.48B |
|
| Cash Flow Statement Financials | |
$4.53B |
|
$-2.64B |
|
$-395.00M |
|
$606.00M |
|
|
End Cash |
$2.15B |
$1.54B |
|
$299.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.62 |
|
-- |
|
-- |
|
0.31 |
|
0.47 |
|
69.01% |
|
17.99% |
|
17.99% |
|
25.04% |
|
16.86% |
|
14.44% |
|
$3.66B |
|
-- |
|
-- |
|
-- |
|
0.46 |
|
2.11 |
|
6.86 |
|
53.20 |
|
11.82% |
|
-348.85% |
|
6.62% |
|
8.12% |
|
$16.50 |
|
$2.45 |
|
$3.03 |
|